Showing results (1751-1760 of 2,026) with videos related to
Sort By:
Pageof 203
Clinical Endocrinology|December 21, 2023
High prevalence of severe sleep cycle disruption in de novo acromegaly and underdiagnosis by common clinical screening tools: A prospective, observational, cross-sectional studyAndrew S Powlson, Anand K Annamalai, Samantha Moir, et al.Journal of the American Chemical Society|December 25, 2015
Length-Dependent Formation of Transmembrane Pores by 310-Helical α-Aminoisobutyric Acid FoldamersJennifer E Jones, Vincent Diemer, Catherine Adam, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 16, 2018
Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort studyL M Webster, K Bramham, P T Seed, et al.Hypertension (Dallas, Tex. : 1979)|February 6, 2008
Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitriteAndrew J Webb, Nakul Patel, Stavros Loukogeorgakis, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Clinical and biochemical effects of the renin inhibitor H142 in humansD J Webb, P J Manhem, S G Ball, et al.Hypertension (Dallas, Tex. : 1979)|April 1, 2009
Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failureJeremy P Langrish, Nicholas L Mills, Louise E Bath, et al.Bioorganic & Medicinal Chemistry Letters|June 16, 2009
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109bPhilip J Skinner, Peter J Webb, Carleton R Sage, et al.Journal of Pharmaceutical Sciences|January 1, 1986
Stability of aspirin in solid mixturesD J Ager, K S Alexander, A S Bhatti, et al.Journal of Applied Microbiology|May 22, 2008
Evaluation of sampling tools for environmental sampling of bacterial endospores from porous and nonporous surfacesN B Valentine, M G Butcher, Y-F Su, et al.Infectious Diseases and Therapy|May 14, 2022
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative PathogensTaylor Morrisette, Sara Alosaimy, Abdalhamid M Lagnf, et al.Pageof 203